CTK Biotech

Executive Summary

CTK Biotech is a US-based diagnostics company headquartered in San Diego, founded in 2003. The company develops and manufactures diagnostic tests and reagents, with a primary focus on infectious diseases and autoimmune disorders. Its products are used by clinical laboratories and healthcare providers to aid in disease detection and management. With over two decades of operational history, CTK Biotech has established itself as a reliable player in the in vitro diagnostics (IVD) market, leveraging its expertise in immunoassay and rapid test technologies. The company serves a diverse customer base, including hospitals, reference labs, and point-of-care settings, both domestically and internationally.

Upcoming Catalysts (preview)

• Q3 2026Launch of a novel rapid test for a high-burden infectious disease (e.g., dengue or Zika)65% success
• Q1 2027FDA 510(k) clearance for an autoimmune diagnostic panel targeting early detection of lupus or rheumatoid arthritis60% success
• Q4 2026Strategic distribution partnership with a global diagnostics leader to expand market reach70% success